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Abstract
Platelets can serve as general markers of mitochondrial (dys)function during several human diseases. Whether this holds
true even during sepsis is unknown. Using spectrophotometry, we measured mitochondrial respiratory chain biochemistry
in platelets and triceps brachii muscle of thirty patients with septic shock (within 24 hours from admission to Intensive Care)
and ten surgical controls (during surgery). Results were expressed relative to citrate synthase (CS) activity, a marker of
mitochondrial density. Patients with septic shock had lower nicotinamide adenine dinucleotide dehydrogenase (NADH)/CS
(p = 0.015), complex I/CS (p = 0.018), complex I and III/CS (p,0.001) and complex IV/CS (p = 0.012) activities in platelets but
higher complex I/CS activity (p = 0.021) in triceps brachii muscle than controls. Overall, NADH/CS (r2 = 0.00; p = 0.683)
complex I/CS (r2 = 0.05; p = 0.173), complex I and III/CS (r2 = 0.01; p = 0.485), succinate dehydrogenase (SDH)/CS (r2 = 0.00;
p = 0.884), complex II and III/CS (r2 = 0.00; p = 0.927) and complex IV/CS (r2 = 0.00; p = 0.906) activities in platelets were not
associated with those in triceps brachii muscle. In conclusion, several respiratory chain enzymes were variably inhibited in
platelets, but not in triceps brachii muscle, of patients with septic shock. Sepsis-induced mitochondrial changes in platelets
do not reflect those in other organs.
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Introduction
Sepsis can be complicated by failure of organs distant from the
site of infection, possibly because of a defect in oxygen-dependent
mitochondrial energy production [1]. Underlying mechanisms
may include hypoxia [2,3] and inhibition of mitochondrial
respiratory chain (where oxygen is normally used to generate
adenosine triphosphate) [4].
Skeletal muscle is the tissue most commonly sampled for
measuring mitochondrial biochemistry, even in critically ill
patients [5–9]. It is readily accessible and can be examined
according to well-standardized protocols [10]. During sepsis,
skeletal muscle mitochondrial biochemistry possibly changes in
line with that of other vital organs (liver, for instance [11]).
However, muscle biopsy is an invasive procedure.
Studying platelets isolated from blood may be a valid
alternative, with virtually no side effects. Platelets can serve as
general markers of mitochondrial changes during neurologic
diseases, senescence, diabetes and drug intoxication [12–17].
Whether this holds true during human sepsis remains unknown.
Aim of the present study was to compare platelet mitochondrial
respiratory chain biochemistry with that of skeletal muscle in
patients with septic shock.
Materials and Methods
The study was approved by local Ethics Committee (Comitato
Etico Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena,
Milano, Italy; protocol number 2724 – 18.10.2007) and registered
at ClinicalTrials.gov (NCT00541827).
We enrolled thirty adults admitted to Intensive Care Unit (ICU)
with septic shock [18] who had not received platelets within the
last fifteen days and had not severe thrombocytopenia (,20000
platelets/mm3), coagulopathy (international normalized ratio .
2.0) or known mitochondrial disease.
Within 24 h from admission, venous blood (15 ml) was drawn,
anticoagulated with EDTA and sedimented for 45 min at 4uC.
The top three-quarters of platelet-rich-plasma were centrifuged at
5000 g for 10 min. Pellet was washed with distilled water,
centrifuged at 14500 g for 10 min, washed again with PBS and
finally stored at 280uC (for mitochondrial biochemistry). Electron
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microscopy performed on three samples confirmed that pellet
obtained in this way was formed almost entirely ($80%) of
platelets. Thereafter, three tissue fragments (<0.4 cm3 each) were
surgically taken from the right or left triceps brachii muscle, under
general anaesthesia, and kept in ice. Following removal of blood,
fat and connective tissue, samples were stored in liquid nitrogen
(for mitochondrial biochemistry – see also Table S1), cooled
isopentane (for histology and histochemistry) or 2.5% glutaralde-
hyde in PBS (pH 7.4) (for electron microscopy). The entire
protocol (including contralateral biopsy) was repeated on day
seven if patients were still in ICU.
Ten patients undergoing elective arm surgery (shoulder
replacement or implant removal) under general anaesthesia acted
as controls.
Written informed consent was obtained from septic patients
when they returned conscious (deferred consent) and from surgical
patients before surgery.
Mitochondrial Biochemistry (Platelets and Skeletal
Muscle)
Platelet pellet was diluted in buffer (KCl 120 mmol/l, HEPES
20 mmol/l, MgCl2 5 mmol/l and EGTA 1 mmol/l; pH 7.2)
(300–400 ml), sonicated (two cycles at 60 W for 10 sec) and
centrifuged (750 g for 10 min) at 4uC. Skeletal muscle was diluted
in the same buffer (1:10), homogenized (three cycles at 350 g for
1 min) and centrifuged as above. Activities of nicotinamide
adenine dinucleotide dehydrogenase (NADH) (subunit of complex
I), NADH-ubiquinone 1 reductase (complex I), NADH-cyto-
chrome c reductase (complex I+III), succinate dehydrogenase
(SDH) (subunit of complex II), SDH-cytochrome c reductase
(complex II+III) and cytochrome c oxidase (complex IV), main
components of the mitochondrial respiratory chain, were mea-
sured on supernatants with spectrophotometry at 30uC [19].
Results are expressed relative to citrate synthase activity, a marker
of mitochondrial density [6–9,11,15,16].
Histology and Histochemistry (Skeletal Muscle Only)
Biopsies were evaluated according to standard protocols
[10,20]. Inflammation was evaluated based on general examina-
tion, acid phosphatase staining, surface membrane binding of
antibodies against human-leukocyte-antigen (HLA) class I and
deposition of membrane attack complex (MAC). Glycogen was
stained with Periodic-Acid-Schiff (PAS) method. Complex IV
activity was judged abnormal if the proportion of negative fibres at
double (complex IV and SDH)-labelling was $5%. Defects were
graded as minor (5–19%), mild (20–39%) or moderate ($40%).
Electron Microscopy (Skeletal Muscle Only)
Three random biopsies of patients with septic shock (including
one non-survivor) were post-fixed in 1% osmium tetroxide and
embedded in Epon. Ultra-thin sections were counterstained with
Table 1. Main characteristics of patients with septic shock at ICU admission.
n 30
Surgical/Medical 21/9
Source of infection
Abdomen 19
Lung 10
Central venous line 1
SAPS II 45 (40–53)
SOFA score
Respiration 3 (3–3)
Coagulation 1 (0–1)
Liver 1 (0–2)
Cardiovascular 4 (4–4)
Central nervous system 0 (0–0)
Renal 1 (0–2)
Total 9 (9–11)
Central (or mixed) venous oxygen saturation (%) 76 (66–79)
Blood lactate (mmol/l) 3 (2–6)
Norepinephrine equivalent dose (mg/min) 15 (12–23)
On mechanical ventilation (n) 29
On renal replacement therapy (n) 3
Days from Hospital to ICU admission 1 (0–5)
Hours from ICU admission to study enrolment 20 (13–22)
Length of stay in ICU (days) 12 (5–18)
Discharged alive from Hospital (n) 25
ICU: intensive care unit. SAPS II: simplified acute physiology score II (referred to the first 24 h from admission). SOFA: sepsis-related organ failure assessment (referred to
the first 24 h from admission). Norepinephrine equivalent dose was calculated as norepinephrine (mg/min)+[dopamine (mg/kg/min)42]+epinephrine (mg/min)+
[phenylephrine (mg/min)410] [41]. Central venous oxymetry was monitored in twenty-five patients; mixed venous oxymetry was monitored in five patients. Please note
that most of the patients were firstly resuscitated in the Emergency Department and then transferred to the ICU.
doi:10.1371/journal.pone.0096205.t001
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uranyl acetate and lead citrate. Mitochondrial ultrastructure was
assessed with ZEISS EM-109.
Statistical Analysis
Data collected from same patients on day one and seven were
analyzed independently. Results are presented as means (6SD) or
medians (IQR). Analysis was performed using Student’s t or
Wilcoxon rank sum tests, one-way analysis of variance (ANOVA)
or ANOVA on ranks (Holm-Sidak or Dunn’s method for post-hoc
multiple comparisons). Strength of association between variables
(r2) was assessed with Pearson product moment test. Proportions
were compared using Fisher’s exact test. p,0.05 indicated
statistical significance (SigmaPlot 11.0, Jandel Scientific Software;
San Jose, CA, USA).
Results
Thirty patients with septic shock were studied on day one
(Table 1). They were older (68612 vs. 54612 years of age;
p = 0.020) but similar for sex (17 males and 13 females vs. 6 males
and 4 females; p = 1.000) to controls. Twenty patients were studied
again on day seven.
Platelet Mitochondrial Biochemistry
On day one, platelets of patients with septic shock had lower
NADH, complex I, complex I and III and complex IV (relative to
citrate synthase) activities and higher citrate synthase activity than
controls (Fig. 1). Inhibition of respiratory chain enzymes was
apparently more severe in patients with higher sepsis-related organ
failure assessment (SOFA) score, in those with thrombocytopenia
and in non-survivors (Tables S2–S4). However, when exact values
of SOFA score or platelet count were considered, their association
with platelet mitochondrial biochemistry was usually non-signif-
icant (Fig. S1 and S2). On day seven, platelets of septic patients still
had lower NADH and complex I (relative to citrate synthase)
activities and higher citrate synthase activity than controls (Table
S5).
Skeletal Muscle Mitochondrial Biochemistry
Skeletal muscle mitochondrial biochemistry of patients with
septic shock (even the sickest ones) did not differ from that of
controls, either on day one or seven (Fig. 2 and Tables S5–S9).
The only exception was complex I (relative to citrate synthase)
activity, that was initially higher (and not lower) in septic patients
than in controls.
Skeletal Muscle Histology and Histochemistry
On day one, few necrotic or regenerating fibres were noted in
two (7%) and one (3%) patients. Acid phosphatase staining was
clearly positive around blood vessels in five (17%) patients and in
interstitium in four (13%) patients. Antibodies against HLA class I
diffusely bound to membrane surface of two (7%) patients.
Microvascular deposits of MAC were detected in one (3%) patient.
PAS stain showed a generalized loss of glycogen in fourteen (47%)
Figure 1. Platelet mitochondrial biochemistry during septic shock. Mitochondrial biochemistry was measured on platelets of ten surgical
controls (white bars) and thirty patients with septic shock (,24 h from ICU admission) (black bars). Activities of nicotinamide adenine dinucleotide
dehydrogenase (NADH) (p = 0.015#) (A), complex I (CI) (p = 0.018#) (B), complex I and III (CI+III) (p,0.001) (C), succinate dehydrogenase (SDH)
(p = 0.086) (D), complex II and III (CII+III) (p = 0.672) (E) and complex IV (CIV) (p = 0.012#) (F) are expressed as percentages of citrate synthase (CS)
activity (p = 0.002) (G). Data are reported as means and standard deviations. *p,0.05 vs. controls [Student’s t or (#) Wilcoxon rank sum tests]. Platelet
count (182683 vs. 176663 *103/mm3) did not differ between groups (p = 0.901).
doi:10.1371/journal.pone.0096205.g001
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patients. Few fibres devoid of complex IV (but with normal
succinate dehydrogenase) activity were noted in eight (27%)
patients: defects were always minor except for one, mild, case.
Other aspects of fibre morphology, vacuole density, vessels and
connective tissue were unaltered. On day seven, notes of necrosis
were found in four (out of eighteen) (22%) patients. Defects of
complex IV activity were minor in two (11%) and mild in three
(17%) cases. Other aspects were as above. Findings in controls
were normal.
Skeletal Muscle Electron Microscopy
Electron microscopy did not reveal any significant change.
Mitochondria were typically located near the Z line and had
classical morphology (Fig. S3).
Relationship between Platelet and Skeletal Muscle
Mitochondrial Biochemistry
There was no relationship between platelet and skeletal muscle
respiratory chain enzyme activities in patients with septic shock (on
day one) and controls (Fig. 3). Changes over time in platelets did
not relate to those in skeletal muscle (Table S10).
Discussion
This study demonstrates that mitochondrial biochemistry is
variably perturbed in platelets but not in triceps brachii muscle of
patients with septic shock.
In platelets, the activity of (respiratory chain) complex I and
complex IV largely declined relative to that of (matrix) citrate
synthase, that instead increased. Changes were possibly more
pronounced in more severely ill patients and in non-survivors.
They also tended to be worse in thrombocytopenic patients, as if
mitochondrial dysfunction had accelerated platelet ‘‘death’’ and
clearance. However, these associations should be interpreted with
caution because they only emerged when variables were consid-
ered as dichotomous (low vs. high SOFA score; normal vs.
abnormal platelet count). Overall, it seems that platelet respiratory
chain enzymes are specifically inhibited during human septic
shock and that megakaryocyte mitochondrial biogenesis and
platelet mitochondrial density increase in response to that [21].
Platelet vulnerability may depend on close contact with potentially
toxic circulating compounds [22–24] and deficiency in nuclear-
encoded reactions [9]. Direct hypoperfusion should not be an issue
as platelets reside in blood. One previous study reported lower
platelet complex IV and higher platelet citrate synthase activities
in patients with severe sepsis who finally died compared to those
who did not [25]. One other study noted that platelet respiratory
capacity and mitochondrial cytochrome c content progressively
increase during fatal sepsis (further suggesting, at least, activation
of mitochondrial biogenesis) [24].
In triceps brachii muscle, results were strikingly different.
Mitochondrial biochemistry was similar to that of controls, even
in patients who went on to die. Histology and histochemistry
showed slight and unspecific alterations, including energy substrate
depletion and non-overt inflammation. Histochemistry only
seldom revealed minor-to-mild defects of complex IV activity
and electron microscopy (only performed in three patients) proved
unremarkable.
Figure 2. Skeletal muscle mitochondrial biochemistry during septic shock. Mitochondrial biochemistry was measured on triceps brachii
muscle of ten surgical controls (white bars) and thirty patients with septic shock (,24 h from ICU admission) (black bars). Results of two patients are
not available due to technical troubles. Activities of nicotinamide adenine dinucleotide dehydrogenase (NADH) (p = 0.369) (A), complex I (CI)
(p = 0.021) (B), complex I and III (CI+III) (p = 0.286) (C), succinate dehydrogenase (SDH) (p = 0.432) (D), complex II and III (CII+III) (p = 0.273) (E) and
complex IV (CIV) (p = 0.760) (F) are expressed as percentages of citrate synthase (CS) activity (p = 0.458) (G). Data are reported as means and standard
deviations. *p,0.05 vs. controls (Student’s t test).
doi:10.1371/journal.pone.0096205.g002
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Absence of more significant changes in skeletal muscle
mitochondria was totally unexpected. In fact, other spectropho-
tometric works did show inhibition of complex I and (possibly)
complex IV, with or without a parallel decrease of citrate synthase
activity, in vastus lateralis muscle of patients with sepsis, especially
if severe or prolonged [5–9]. We then purposely studied patients
with septic shock, usually on high dose of catecholamines (those at
higher risk for mitochondrial dysfunction [6]), either on day one or
seven. We performed subgroup analysis to select most severe cases
and complemented biochemistry with histology, histochemistry
and electron microscopy. Even so, all our efforts to detect
(predicted) signs of mitochondrial dysfunction were vain.
Our present work differs from those reported above because it
examined mitochondrial function in triceps brachii, and not in
vastus lateralis, muscle. Muscles differ in their mitochondrial
content or activity [26], susceptibility to oxidative damage [27]
and blood flow [28]. As a consequence, sepsis may diversely affect
different muscles, just as other systemic insults do [29]. In animals,
sepsis changes mitochondrial integrity [30,31], adenosine triphos-
phate levels [32] and protein turnover [33,34] in some muscle
groups more than in others. In humans, it apparently affects
mitochondrial morphology in liver but not in rectus abdominis
[35], triggers mitochondrial biogenesis in rectus abdominis, but
not in vastus lateralis [36], induces energy failure in vastus
lateralis, but not in serratus anterior, muscle [7]. Therefore
discrepancy between present and past findings in skeletal muscle
probably reflects compartmentalization of response to infection
[37]. However, we cannot exclude that it simply indicates that
skeletal muscle mitochondrial biochemistry is not, at least
constantly, altered during sepsis [38].
Some aspects of this study deserve a comment. First, muscle
biopsies were not immediately frozen in liquid nitrogen. We
considered important to remove contaminants to measure ‘‘pure’’
skeletal muscle mitochondrial biochemistry. In retrospect, this was
probably not a very relevant issue. In fact, results did not differ
between samples processed as above and those snap-frozen (please
also refer to Table S1). Moreover, changes in platelet mitochon-
drial biochemistry could be readily detected even if pellet
preparation required approximately one hour. Second, we did
not measure markers of apoptosis that, according to other authors,
are associated with platelet mitochondrial dysfunction and
thrombocytopenia [39,40]. Third, our study population included
only few patients with fatal septic shock, who are more likely to
develop skeletal muscle mitochondrial dysfunction [6]. However,
our primary end-point was to clarify whether findings in platelets
can be extrapolated to other organs. Regardless of severity of
disease, mitochondrial respiratory chain biochemistry was largely
inhibited in platelets but not in triceps brachii muscle. Fourth, our
negative results do not exclude that aspects of skeletal muscle
mitochondrial physiology not presently investigated may well
derange during human sepsis.
In conclusion, sepsis-induced mitochondrial changes in human
platelets are not associated with those in triceps brachii muscle.
Findings in blood cells (or other specific tissues) may not reflect
Figure 3. Relationship between platelet and skeletal muscle mitochondrial biochemistry. Mitochondrial biochemistry was measured on
platelets (Y-axis) and triceps brachii muscle (X-axis) of ten surgical controls (white dots) and thirty patients with septic shock (,24 h from ICU
admission) (black dots). Results of skeletal muscle mitochondrial biochemistry of two patients are not available due to technical troubles. Activities of
nicotinamide adenine dinucleotide dehydrogenase (NADH) (A), complex I (CI) (B), complex I and III (CI+III) (C), succinate dehydrogenase (SDH) (D),
complex II and III (CII+III) (E) and complex IV (CIV) (F) are expressed as percentages of citrate synthase (CS) activity (G). r2 and p values refer to Pearson
product moment test.
doi:10.1371/journal.pone.0096205.g003
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those in other organs and therefore should not be generalized.
Further studies are needed to clarify the role of mitochondrial
dysfunction in the pathogenesis of human sepsis.
Supporting Information
Figure S1 Relationship between severity of disease and
platelet mitochondrial biochemistry. Platelet mitochondrial
biochemistry (Y-axis) and sepsis-related organ failure assessment
(SOFA) score (X-axis) were measured in thirty patients with septic
shock (,24 h from ICU admission). Activities of nicotinamide
adenine dinucleotide dehydrogenase (NADH) (A), complex I (CI)
(B), complex I and III (CI+III) (C), succinate dehydrogenase
(SDH) (D), complex II and III (CII+III) (E) and complex IV (CIV)
(F) are expressed as percentages of citrate synthase (CS) activity
(G). r2 and p values refer to Pearson product moment test.
(DOC)
Figure S2 Relationship between platelet count and
mitochondrial biochemistry. Platelet mitochondrial bio-
chemistry (Y-axis) and platelet count (X-axis) were measured in
ten surgical controls (white dots) and thirty patients with septic
shock (,24 h from ICU admission) (black dots). Activities of
nicotinamide adenine dinucleotide dehydrogenase (NADH) (A),
complex I (CI) (B), complex I and III (CI+III) (C), succinate
dehydrogenase (SDH) (D), complex II and III (CII+III) (E) and
complex IV (CIV) (F) are expressed as percentages of citrate
synthase (CS) activity (G). r2 and p values refer to Pearson product
moment test.
(DOC)
Figure S3 Skeletal muscle mitochondrial ultrastructure
during septic shock. Electron microscopy was performed in
three patients with septic shock (including one non-survivor) to
confirm normal findings at biochemistry, histology and histo-
chemistry. Mitochondria appear classically located near the Z-line,
with normal morphology and ultrastructure. Original magnifica-
tion: x 7000 (A), x 12000 (B, detail of A), x 30000 (C), x 12000 (D).
(DOC)
Table S1 Skeletal muscle mitochondrial biochemistry:
effect of time from biopsy to storage in liquid nitrogen.
Skeletal muscle mitochondrial biochemistry was always measured
on samples that were frozen in liquid nitrogen within 10–15 min
from biopsy. In five surgical controls and five patients with septic
shock, one additional sample was immediately (snap) frozen in
liquid nitrogen. Results obtained from samples processed in either
way are reported. NADH: nicotinamide adenine dinucleotide
dehydrogenase. SDH: succinate dehydrogenase. CS: citrate
synthase. p values refer to paired Student’s t or Wilcoxon rank
sum tests.
(DOC)
Table S2 Platelet mitochondrial biochemistry in pa-
tients with septic shock and low or high sepsis-related
organ failure assessment (SOFA) score. Mitochondrial
biochemistry was measured on platelets of ten surgical controls
and thirty patients with septic shock (,24 h from ICU admission).
Median SOFA score of patients with septic shock was 9. Patients
with SOFA score #9 were classified as ‘‘less severe’’ and those
with SOFA score .9 as ‘‘more severe’’. NADH: nicotinamide
adenine dinucleotide dehydrogenase. SDH: succinate dehydroge-
nase. CS: citrate synthase. p values refer to Student’s t or Wilcoxon
rank sum tests, one-way ANOVA or ANOVA on ranks. *p,0.05
vs. surgical controls on post-hoc comparisons (Holm-Sidak or
Dunn’s method).
(DOC)
Table S3 Platelet mitochondrial biochemistry in pa-
tients with septic shock and low or normal platelet
count. Mitochondrial biochemistry was measured on platelets of
ten surgical controls and thirty patients with septic shock (,24 h
from ICU admission). Platelet count was considered normal if
higher than 150*103/mm3. NADH: nicotinamide adenine dinu-
cleotide dehydrogenase. SDH: succinate dehydrogenase. CS:
citrate synthase. p values refer to one-way ANOVA or ANOVA
on ranks. *p,0.05 vs. surgical controls on post-hoc comparisons
(Holm-Sidak or Dunn’s method).
(DOC)
Table S4 Platelet mitochondrial biochemistry in pa-
tients with fatal or non-fatal septic shock. Mitochondrial
biochemistry was measured on platelets of ten surgical controls
and thirty patients with septic shock (,24 h from ICU admission).
Based on hospital outcome, patients with septic shock were
classified as ‘‘survivors’’ or ‘‘non-survivors’’. NADH: nicotinamide
adenine dinucleotide dehydrogenase. SDH: succinate dehydroge-
nase. CS: citrate synthase. p values refer to one-way ANOVA or
ANOVA on ranks. *p,0.05 vs. surgical controls on post-hoc
comparisons (Holm-Sidak or Dunn’s method).
(DOC)
Table S5 Platelet and skeletal muscle mitochondrial
biochemistry during septic shock (day seven). Mitochon-
drial biochemistry was measured on platelets and triceps brachii
muscle of ten surgical controls and twenty (out of thirty) patients
with (or recovering from) septic shock, seven days after ICU
admission. By day seven, nine patients had already been
discharged from the ICU (three deaths) and one had developed
severe thrombocytopenia. On day seven, only five patients were
still on catecholamine(s) and median SOFA score was 5 (3–6) (p,
0.001 vs. median SOFA score on day one). Results of
mitochondrial biochemistry of three patients are not fully available
due to technical troubles. NADH: nicotinamide adenine dinucle-
otide dehydrogenase. SDH: succinate dehydrogenase. CS: citrate
synthase. p values refer to Student’s t or Wilcoxon rank sum tests.
(DOC)
Table S6 Skeletal muscle mitochondrial biochemistry
in patients with septic shock and low or high sepsis-
related organ failure assessment (SOFA) score. Mito-
chondrial biochemistry was measured on triceps brachii muscle of
ten surgical controls and twenty-eight patients with septic shock (,
24 h from ICU admission). Median SOFA score of patients with
septic shock was 9. Patients with SOFA score #9 were classified as
‘‘less severe’’ and those with SOFA score .9 as ‘‘more severe’’.
NADH: nicotinamide adenine dinucleotide dehydrogenase. SDH:
succinate dehydrogenase. CS: citrate synthase. p values refer to
Student’s t or Wilcoxon rank sum tests, one-way ANOVA or
ANOVA on ranks. *p,0.05 vs. surgical controls on post-hoc
comparisons (Holm-Sidak or Dunn’s method).
(DOC)
Table S7 Skeletal muscle mitochondrial biochemistry
in patients with septic shock and low or high central (or
mixed) venous oxygen saturation. Mitochondrial biochem-
istry was measured on triceps brachii muscle of ten surgical
controls and twenty-eight patients with septic shock (,24 h from
ICU admission). Patients with venous oxygen saturation $70%
were classified as ‘‘normoxic’’ and those with venous oxygen
saturation ,65% as ‘‘hypoxic’’ (two patients with venous oxygen
saturation between 65–70% were excluded from this analysis).
NADH: nicotinamide adenine dinucleotide dehydrogenase. SDH:
succinate dehydrogenase. CS: citrate synthase. p values refer to
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Student’s t or Wilcoxon rank sum tests, one-way ANOVA or
ANOVA on ranks. *p,0.05 vs. surgical controls on post-hoc
comparisons (Holm-Sidak or Dunn’s method).
(DOC)
Table S8 Skeletal muscle mitochondrial biochemistry
in patients with septic shock with low or high lactate
blood level. Mitochondrial biochemistry was measured on
triceps brachii muscle of ten surgical controls and twenty-eight
patients with septic shock (,24 h from ICU admission). Patients
with blood lactate ,2 mmol/l were classified as ‘‘normoxic’’ and
those with blood lactate .5 mmol/l as ‘‘hypoxic’’ (eight patients
with blood lactate between 2–5 mmol/l were excluded from this
analysis). NADH: nicotinamide adenine dinucleotide dehydroge-
nase. SDH: succinate dehydrogenase. CS: citrate synthase. p
values refer to Student’s t or Wilcoxon rank sum tests, one-way
ANOVA or ANOVA on ranks. *p,0.05 vs. surgical controls on
post-hoc comparisons (Holm-Sidak or Dunn’s method).
(DOC)
Table S9 Skeletal muscle mitochondrial biochemistry
in patients with fatal or non-fatal septic shock. Mito-
chondrial biochemistry was measured on triceps brachii muscle of
ten surgical controls and twenty-eight patients with septic shock (,
24 h from ICU admission). Based on hospital outcome, patients
with septic shock were classified as ‘‘survivors’’ and ‘‘non-
survivors’’. NADH: nicotinamide adenine dinucleotide dehydro-
genase. SDH: succinate dehydrogenase. CS: citrate synthase. p
values refer to one-way ANOVA or ANOVA on ranks. *p,0.05
vs. surgical controls on post-hoc comparisons (Holm-Sidak or
Dunn’s method).
(DOC)
Table S10 Relationship between changes over time of
platelet and skeletal muscle mitochondrial biochemis-
try. Mitochondrial biochemistry of platelets and triceps brachii
muscle was assessed on day one and seven in fifteen patients with
septic shock. Results of mitochondrial biochemistry of five patients
are not fully available due to technical troubles. NADH:
nicotinamide adenine dinucleotide dehydrogenase. SDH: succi-
nate dehydrogenase. CS: citrate synthase. r2 and p values refer to
Pearson product moment tests.
(DOC)
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